There are currently three types of HPV vaccines available: Gardasil 9, Gardasil, and Cervarix. Gardasil 9 protects against nine of the most common HPV strains, offering up to 90% protection ...

In comparison to the 18% efficacy seen by Gardasil, the efficacy of Cervarix in the naive total vaccinated cohort was 70% against all CIN 2+ regardless of HPV causation, and 30% in the total ...

Gardasil is approved by the FDA for girls and women ages 9 to 26. The CDC and the American ... There's a second vaccine in the works: Cervarix, from GlaxoSmithKline. Cervarix targets two HPV ...

Gardasil has also been licensed in over 40 countries worldwide. Cervarix is awaiting European ... Expert Rev. Mol. Med. 6(9), 1-21 (2004).

Ninety-nine percent of cervical cancers are caused by HPV. What is the Cervarix HPV vaccine? The Cervarix HPV vaccine protects against the two strains of HPV (16 and 18) that cause cervical cancer ...

The first vaccine used was GlaxoSmithKline's Cervarix, which was replaced by MSD's Gardasil in 2012. The research by King's College London is the first direct evidence that HPV vaccination makes a ...